Dudhal SC, Hapse SA, Kothule MB.
email@example.com , firstname.lastname@example.org
Dudhal S.C.1*, Hapse S.A.1, Kothule M.B. 2
1Department of Quality Assurance Technique, P.D.V.V.P.F’S College of Pharmacy, Ahmednagar
2H.S.B.P.V.T. College of Pharmacy, Kashti Tal. Shrigonda, Ahmednagar
Volume - 6,
Issue - 4,
Year - 2014
Ebola hemorrhagic fever (Ebola HF) is a severe, often-fatal disease in humans and nonhuman primates (monkeys and chimpanzees) that has appeared sporadically since its initial recognition in 1976.Most species of ebolavirus and the only known species of virus occur in Africa. Primates are infected sporadically from an unknown source; current evidence suggests that the reservoir hosts are probably bats. Humans seem to become infected directly from bats in caves, as well as when they contact tissues from infected apes and other species. Once the virus has entered the population, it can spread from person to person. Some epidemics affect hundreds of people and decimate entire villages, particularly where hospital facilities and medical supplies are inadequate and nosocomial spread occurs. Although the mortality rate varies, the most pathogenic viruses kill up to 90% of those who become infected. No vaccine is available, and the only treatment is supportive.
Cite this article:
Dudhal SC, Hapse SA, Kothule MB. An Ebola: Overview. Research Journal of Pharmacology and Pharmacodynamics. 2014; 6(4): 204-209.
Dudhal SC, Hapse SA, Kothule MB. An Ebola: Overview. Research Journal of Pharmacology and Pharmacodynamics. 2014; 6(4): 204-209. Available on: https://rjppd.org/AbstractView.aspx?PID=2014-6-4-16